PWNHealth Receives Significant Growth Investment Led by Spectrum Equity
09/17/20, 10:02 AM
Location
new yorkPWNHealth, a leading provider of healthcare diagnostic testing enablement solutions, announced today that it has received a significant growth investment led by Spectrum Equity, a leading growth equity firm focused on internet-enabled software and information services companies, with participation by the Blue Venture Fund (BVF), a unique collaboration between Blue Cross and Blue Shield (BCBS) companies, Blue Cross Blue Shield Association (BCBSA), and Sandbox to which thirty-six BCBS companies have committed over $800 million across four funds. The investment will enable PWNHealth to continue to expand its product offering to direct-to-consumer testing brands, diagnostic testing laboratories, health plans, and life sciences companies.
Company Info
Location
new york, new york, united states
Additional Info
PWNHealth is a national clinician network working to improve early detection and prevention of disease using advanced diagnostics and telehealth. PWN services all 50 states and Puerto Rico with telehealth and telegenetic services. Our model enables safe and easy access to diagnostic testing, ensuring clinical validity, utility, quality consumer education, access to clinicians, and the ability to implement national programs seamlessly. Our solutions provide the clinical, legal, and technological framework to facilitate population-scale testing across key healthcare markets. Through integration with more than 80 CLIA-certified labs and support of over 3,000 test types, we are shaping a new paradigm in healthcare. We believe that empowering people with convenient access to clinically actionable testing has the power to change lives, improve outcomes, and create a healthier world. For more information, visit www.pwnhealth.com.